03.28.19

European Patents Found to be Invalid and Deemed Impotent in the Highest British Court (Again)

Posted in Courtroom, Europe, Patents at 12:42 pm by Dr. Roy Schestowitz

It’s about the tadalafil generic

Just gimme the hands

Summary: “Just gimme the patent,” says every greedy corporation looking to ban its competition (including generics) and facilitate monopoly pricing; the problem is, the EPO keeps granting invalid patents that take a lot of time and money to formally invalidate (in courts), as Actavis v ICOS has just shown

THE number of patents granted by the U.S. Patent and Trademark Office (USPTO) declined last year after certainty associated with these patents had declined and then number of patent lawsuits had totally collapsed. We now see something similar going on in Europe. Was it inevitable? Couldn’t we learn from the mistakes of American lawmakers and USPTO officials?

We are pleased to see that IP Kat (Rose Hughes) has recently been covering some cases that relate to the European Patent Office (EPO). Hughes is doing an OK job without coming across as a patent extremist like the Bristows staff at IP Kat and yesterday she wrote this article about a (British) Supreme Court outcome. Yet another EPO-granted patent has been found to be nonsense:

This morning, the UK Supreme Court delivered its decision in Actavis v ICOS [2019] USKC 15, upholding the Court of Appeal’s decision that ICOS’s dosage regimen patent was obvious. In doing so, the Supreme Court (in a welcome change…) has followed the previous approach of the lower courts to the question of inventive step in both the UK courts and in the jurisprudence of the EPO.

The patent in question related to tadalafil (branded as CIALIS). Tadalafil is an orally administered drug for treating sexual dysfunction. Tadalafil works in a similar way to Pfizer’s famous blockbuster drug Viagra, but with fewer side effects. The original first medical use patent for tadalafil (EP 0740668, “Daugan”) and its associated SPC have both expired. The latest decision related to ICOS’s patent (EP 1173181) which claimed a particular dosage regime of tadalafil. Lilly is the exclusive licensee of the patent.

In an attempt to clear the market for their own tadalafil generic, Actavis brought revocation proceedings against the ICOS/Lilly patent. Actavis argued that the claims lacked novelty and inventive step in view of the original tadalafil patent (“Daugan”). The contentious claims related to a dose regime of up to 5mg tadalafil per day. The Court of Appeal, in overturning Mr Justice Birss’ decision, found the patent invalid for lack of inventive step (Actavis v ICOS [2017] EWCA Civ 1671). Particularly, it was found that the claimed dose would have been obvious for the skilled person to try (IPKat post here).

Notice that first comment which asks: “Can every one of Lord Hodge’s 9 factors be accommodated within Lord Hodge’s exposition of the EPO’s Problem and Solution Approach? If not all, which ones not?”

“Can every one of Lord Hodge’s 9 factors be accommodated within Lord Hodge’s exposition of the EPO’s Problem and Solution Approach?”
      –Anonymous
Someone “from France” then added: “One important factor seems indeed to be missing, which is the “reasonable expectation of success”, even though certain of the listed factors are usually considered for applying this factor. The reasoning that the clinical trial is somewhat a “one way street” (to use EPO standards) is not completely out of scope, but the specific dosage finding that has been identified for optimal effect could, in my view, not have been necessarily derived from this approach (the dosage plateau could not have been expected, considering it seems to necessarily imply some hindsight). I’m not sure I agree with the comment in the post that such a decision is welcome…, I can hardly consider a diverging view between the EPO and national courts to be welcome.”

Another anonymous commenter quotes: “The original first medical use patent for tadalafil (EP 0740668, “Daugan”) and its associated SPC have both expired.”

Then comes the question (or questions): “Doesn’t this mean it has already passed through clinical trials? By the courts’ logic should a 5mg dose already be known? What have I missed?”

What about public interests as well? Either way, the court has trashed yet another European Patent. Will António Campinos get the message or just keep on lying about quality?

“I can hardly consider a diverging view between the EPO and national courts to be welcome.”
      –Anonymous
Freshfields Bruckhaus Deringer LLP’s Laura Whiting and Paul Abbott wrote about it this morning (publication time), calling it “its second patent decision in 6 months” (so rarely do we get to see, at least at this level, just how awful the quality of patents has become).

We’ll probably hear a lot more about it in days if not weeks to come.

Share in other sites/networks: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Reddit
  • email

This post is also available in Gemini over at:

gemini://gemini.techrights.org/2019/03/28/tadalafil-generic/

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Gemini Capsules and Pages Now Accessible in a Web Browser, Qutebrowser, But Qutebrowser Has Issues

    As noted earlier this morning, it's nowadays possible to access Gemini capsules through a Web browser without any Web proxies; but the (likely) first browser with that capability has numerous big issues



  2. IRC Proceedings: Sunday, March 07, 2021

    IRC logs for Sunday, March 07, 2021



  3. Moving Away From the World Wide Web is a Wise Move, at Least to the Degree Which is Possible

    More Web browsers finally support the Gemini protocol and decentralisation is gaining traction (it's even in mainstream European media right about now)



  4. The Banality of Bribery

    To understand why institutions defend and sometimes even give awards for the very things they claim to be against one must examine the flow of money (with strings attached to it)



  5. When I Discovered People Trafficking in Free/Open Source Software

    Reprinted with permission from Daniel Pocock



  6. Links 7/3/2021: AviDemux 2.7.8, Thunar 4.16.4

    Links for the day



  7. Links 7/3/2021: Sparky 2021.03, SystemRescue 8.00, and FreeBSD 13.0 RC1

    Links for the day



  8. IRC Proceedings: Saturday, March 06, 2021

    IRC logs for Saturday, March 06, 2021



  9. How To Deal With Your Raspberry Spy -- Part V: All The Rest

    The final part of a series on liberating the Raspberry Spy from an untrustworthy OS that secretly adds Microsoft keys and proprietary software repositories of Microsoft



  10. How To Deal With Your Raspberry Spy -- Part IV: Doing The Task

    We now spell out the steps taken to actually replace the Raspberry Pi OS with something more trustworthy



  11. Corporations Do Not Represent Communities and Activists, They Just Exploit Them, Discredit Them, and Hijack Their Hard Work

    The AstroTurfing and the Googlebombing campaigns of large corporations would have us believe that genuine activists are toxic and malicious people, whereas corporations exist to save the world from evil people; don’t fall for those Public Relations tactics (a gross inversion of narrative)



  12. Why the 'Raspberry Spy' Blunder is a Lot More Serious and Profound Than the Corporate Media is Willing to Acknowledge

    As this video points out, the ongoing series by Gavin L. Rebeiro is justified by the fact that the 'Raspberry Spy' Foundation continues to work with and some might say for Microsoft; it sold out millions of customers



  13. Links 6/3/2021: “SLS” Mitigation and Exiv2/KDE Project

    Links for the day



  14. How To Deal With Your Raspberry Spy -- Part III: Fundamentals

    Following the introductory and preliminary parts we dive deeper into the steps taken to replace the Raspberry Pi's GNU- and Linux-based OS with something like NetBSD



  15. Links 6/3/2021: Linux 5.12 RC2 and OpenSUSE Tumbleweed Woes

    Links for the day



  16. IRC Proceedings: Friday, March 05, 2021

    IRC logs for Friday, March 05, 2021



  17. Links 5/3/2021: Qubes OS 4.0.4 Release and Wine's Project Leader is Open to Wayland

    Links for the day



  18. How To Deal With Your Raspberry Spy -- Part II: Introduction

    Following Part I, published a few hours ago, let's examine what happened from a technical perspective and what can be done about it technically



  19. How To Deal With Your Raspberry Spy -- Part I: Acknowledgements

    March 2, 2021 blog post series from a guest author; for some background, see blog posts from Microsoft in the official blog of Raspberry Pi and our response to these



  20. German Decision on Unitary Patent/UPC Will Take Years (and It Doesn't Matter Because the Whole Thing is Dead Already)

    Kluwer Patent Blog's Dr. Bausch explains why the UPC is pretty much doomed, as it cannot be ratified any time soon and probably will never be ratified either (for a multitude of reasons, including Brexit)



  21. Techrights in Australia (IPFS and Gemini)

    Allies in Australia will help Techrights serve material from another server; we're still bettering ourselves for an era of oppressive World Wide Web



  22. Professional Troll Matthew Garrett Spreads Libel, Defamation and Slander About the Free Software Community to Entertain Microsoft and Friends

    After months of parking in our IRC channels to provoke and troll people (and try to collect 'dirt' from responses) the professional troll Matthew Garrett has been for many years shows his true colours again



  23. Links 5/3/2021: Linux 5.12-rc2 Imminent, Linux Lite 5.4 RC1 in Review

    Links for the day



  24. IRC Proceedings: Thursday, March 04, 2021

    IRC logs for Thursday, March 04, 2021



  25. Links 4/3/2021: LibreOffice 7.1.1, Cockpit 239, Many Stable Kernel Releases

    Links for the day



  26. Links 4/3/2021: Pardus 19.5 is Out and Free Software Foundation Gets Consulting Grant

    Links for the day



  27. IRC Proceedings: Wednesday, March 03, 2021

    IRC logs for Wednesday, March 03, 2021



  28. The Free Software Foundation Should Re-add Richard Stallman to the Board

    Dr. Richard Stallman is missed by many who perceive him to have been wrongly treated; putting Stallman back in the Board (at the very least) would help the image of the Free Software Foundation more than the newly-announced work with Community Consulting Teams of Boston



  29. Free Software Calling

    Fewer people are willing to "put up with the shit" given by so-called 'Big Tech', seeing that it's mostly about social control rather than enablement or emancipation



  30. Meme: EPO Management Totally Gets 'Tehc'

    The bestest patent office in the whole wide world is besting the “hey hi” (AI) cutting edge; don't worry about exam and certification integrity


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts